Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)
Schifferli A, Ruefer A, Rovo A, Cantoni N, Holbro A, Favre G, Faeth H, Pereira RR, Wieland A, Dirks J, Nimmerjahn F, Kuehne T (2021)
Publication Type: Conference contribution
Publication year: 2021
Journal
Publisher: AMER SOC HEMATOLOGY
City/Town: WASHINGTON
Conference Proceedings Title: BLOOD
DOI: 10.1182/blood-2021-146648
Authors with CRIS profile
Involved external institutions
Universitäts-Kinderspital beider Basel (UKBB)
Switzerland (CH)
Luzerner Kantonsspital (LUKS)
Switzerland (CH)
Inselspital, Universitätsspital Bern
Switzerland (CH)
Kantonsspital Aarau AG
Switzerland (CH)
Universitätsspital Basel
Switzerland (CH)
Universität Basel
Switzerland (CH)
Kantonsspital Baselland
Switzerland (CH)
Switzerland (CH)
Luzerner Kantonsspital (LUKS)
Switzerland (CH)
Inselspital, Universitätsspital Bern
Switzerland (CH)
Kantonsspital Aarau AG
Switzerland (CH)
Universitätsspital Basel
Switzerland (CH)
Universität Basel
Switzerland (CH)
Kantonsspital Baselland
Switzerland (CH)
How to cite
APA:
Schifferli, A., Ruefer, A., Rovo, A., Cantoni, N., Holbro, A., Favre, G.,... Kuehne, T. (2021). Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study). In BLOOD. WASHINGTON: AMER SOC HEMATOLOGY.
MLA:
Schifferli, Alexandra, et al. "Immunomodulation with Romiplostim in Young Adult Primary Immune Thrombocytopenia (ITP) As Second-Line Strategy (iROM-study)." Proceedings of the BLOOD WASHINGTON: AMER SOC HEMATOLOGY, 2021.
BibTeX: Download